China Pharma HOLDINGS, Inc. (CPHI) intrinsic value & 10-year financials
China Pharma HOLDINGS, Inc. (CPHI) has a Graham intrinsic value of $12.04 per share. At $0.71 on Oct 17, 2026, the stock trades 94% below that value. Over the last 10 fiscal years revenue shrank 13.7% a year to $4.1M, with an average return on invested capital of -68.9%.
- Graham intrinsic value
- $12.04
- Share price (Oct 17, 2026)
- $0.71
- Price vs Graham value
- 94% below
- Market cap
- $3.1M
- Revenue (FY2025)
- $4.1M
- Revenue growth (10-yr CAGR)
- -13.7%
- ROIC (10-yr avg)
- -68.9%
- Free cash flow (FY2025)
- $88.9K
CPHI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $4.1M | -$3.2M | -$0.74 | $88.9K | -78.2% | -19.8% |
| FY2024 | $4.5M | -$4.7M | -$0.27 | -$504.8K | -101.3% | -61.1% |
| FY2023 | $7.0M | -$3.1M | -$0.91 | -$711.2K | -39.2% | -42.7% |
| FY2022 | $8.1M | -$4.0M | -$0.76 | -$811.5K | -43.8% | -330.2% |
| FY2021 | $9.6M | -$3.4M | -$0.74 | -$687.9K | -29.7% | -50.4% |
| FY2020 | $10.9M | -$2.9M | — | -$909.6K | -23.7% | -23.1% |
| FY2019 | $10.9M | -$20.7M | — | $472.3K | -186.8% | -86.1% |
| FY2018 | $12.3M | -$10.8M | — | $1.2M | -84.7% | -24.1% |
| FY2017 | $13.2M | -$19.3M | — | $704.7K | -141.4% | -37.2% |
| FY2016 | $15.6M | -$9.2M | — | $2.7M | -52.4% | -13.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CHINA PHARMA HOLDINGS, INC. is facing top-line stagnation, with revenue contracting over the decade.
CHINA PHARMA HOLDINGS, INC. has historically struggled to out-earn its cost of capital, averaging just -36.2% ROIC.
CHINA PHARMA HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CHINA PHARMA HOLDINGS, INC. is modeled at -13.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $12.04 per share.